Did you mean
changes

Search results - 9 results

Replacement of Diphtheria and Tetanus potency challenge method by serology in mice

Publication Type: Scientific poster, presentation or proceeding Authors: J. Auquier Source: Annual OMCL Meeting 2023, EDQM, Madrid (2023) Keywords: 3R Diphtheria serology Tetanus vaccine Health Topics:  Vaccin Vaccin Vaccin Service:  Qualité des vaccins e ...

Regulatory Position on Specification Settings

Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing Countries, ...

Round table discussion on posters: comparability and testing challenges

Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing ...

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Finally, protein boosting increased the protective efficacy of the DNA vaccine against an intravenous M. tuberculosis H37R v challenge infection, as measured by CFU or relative light unit counts in lungs ...

Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.

M. tuberculosis challenge, as measured by reduced numbers of CFU in spleen and lungs, compared to animals vaccinated with control DNA. Gene gun immunization was not effective in either BALB /c or C57BL ...

Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.

and protection against intravenous M. tuberculosis challenge. Whereas DNA vaccination induced elevated antibody responses in C57BL /6 and particularly in C3H mice, Th1-type cytokine response, as ...

Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.

DNA Abstract: OBJECTIVE: To determine the efficacy of Ag85A- DNA against challenge with a highly virulent human clinical isolate of Mycobacterium tuberculosis (CSU37) and to compare the potencies of two ...

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

lungs from B6 mice, subsequently challenged. Therefore, this technique may be useful for the definition of protective antigens of M. tuberculosis and the development of a more effective ...

QR code

QR code for this page URL